[Form 4] Planet Labs PBC Insider Trading Activity

Rhea-AI Filing Summary

Planet Labs PBC (PL) – Form 4 filing dated 10 July 2025

The filing discloses routine equity grants to director Ita M. Brennan. Two separate awards of Class A common stock restricted stock units (RSUs) were reported:

• 32,468 RSUs that vest fully on the earlier of the first anniversary of grant or the next annual shareholders’ meeting.
• 13,915 RSUs that vest in equal quarterly tranches each 15 March, 15 June, 15 September and 15 December.

No cash consideration was paid (price $0), and no derivative transactions were reported. Following the grants, Brennan’s direct beneficial ownership rose to 298,968 Class A shares, all held directly.

The awards are part of the company’s standard director compensation program and do not alter share count materially. There is no indication of open-market buying or selling, and the transaction does not involve Rule 10b5-1 trading plans.

Insights

Corporate Governance Expert

TL;DR – Standard director RSU grants; negligible company impact.

The Form 4 records scheduled equity compensation to non-employee director Ita M. Brennan. Both awards follow typical board-level vesting structures designed to align director incentives with shareholder interests. With only ~46k new RSUs granted, dilution is immaterial relative to Planet Labs’ ~283 million basic shares outstanding. No sale or option exercise occurred, so the filing neither signals insider confidence nor raises liquidity concerns. Governance wise, time-based vesting through the next AGM promotes continuous board service and is industry standard.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brennan Ita M

(Last) (First) (Middle)

C/O PLANET LABS PBC

645 HARRISON STREET, FLOOR 4

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Planet Labs PBC [ PL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/10/2025		A		32,468(1)	A	$0	285,053(1)	D
Class A Common Stock	07/10/2025		A		13,915(2)	A	$0	298,968(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 32,468 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

2. Includes 13,915 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

3. Includes (a) 13,915 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June; and (b) 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Remarks:

	By: /s/ LeeAnn Linck, Attorney-in-fact for: Ita M Brennan	07/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Planet Labs (PL) shares did director Ita Brennan receive on 10 July 2025?

46,383 RSUs were granted (32,468 + 13,915), each convertible to one Class A share.

What is the vesting schedule for the new RSUs granted to Ita Brennan?

32,468 RSUs vest at the earlier of one year or the next AGM; 13,915 RSUs vest quarterly on 15 Mar, 15 Jun, 15 Sep and 15 Dec.

Did Ita Brennan buy or sell Planet Labs stock on the open market?

No. The filing only reports equity grants at $0 cost; no purchases or sales were disclosed.

What is Ita Brennan’s total direct ownership in Planet Labs after the grant?

The director now directly owns 298,968 Class A shares (including unvested RSUs).

Does the Form 4 mention a Rule 10b5-1 trading plan?

No. The checkbox for Rule 10b5-1 trades is not marked; these are standard compensation grants.